1-3 of 3
Jianli Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Studies Support the Clinical Development of LP-284 in Relapsed and Refractory B-Cell Lymphomas

Jianli Zhou, Drew Sturtevant, Aditya Kulkarni, Kishor Bhatia, Reginald Ewesuedo
Journal: Blood
Blood (2023) 142 (Supplement 1): 7143.
https://doi.org/10.1182/blood-2023-174964
Published: 2023
Journal Articles

Development of a Potent DNA Damaging Agent LP-284 for Treatment of Mantle Cell Lymphoma

Jianli Zhou, Aditya Kulkarni, Cassandra Love, Lanie Happ, Drew Sturtevant, Neha Biyani, Raniero L. Peru y Colón De Portugal, Kishor Bhatia, Sandeep S. Dave
Journal: Blood
Blood (2022) 140 (Supplement 1): 4940–4941.
https://doi.org/10.1182/blood-2022-160247
Published: 2022
Journal Articles

The Positive Enantiomer of a Novel Chiral DNA Alkylating Agent Exhibits Nanomolar Potency in Hematologic Cancers

Jianli Zhou, Neha Biyani, Umesh Kathad, Aditya Kulkarni, Joseph McDermott, Kishor Bhatia
Journal: Blood
Blood (2021) 138 (Supplement 1): 3991.
https://doi.org/10.1182/blood-2021-147989
Published: 2021